4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001628280-24-043462
Options or other derivatives
- Chief Financial Officer acquired 146,544 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Pamir Ozan · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-10-21 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +146,544 | 146,544 | D |
Loading xslF345X05/wk-form4_1729717442.xml…